ADVANCED ENZYME TECHNOLOGIES
Quarterly Results Analysis [Jun2025]
ADVANCED ENZYME TECHNOLOGIES Quarterly Results
Consolidated | Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹186 Cr | ₹167 Cr | ₹169 Cr | ₹146 Cr | ₹155 Cr | ₹158 Cr | ₹161 Cr | ₹158 Cr |
Expenses | ₹129 Cr | ₹122 Cr | ₹114 Cr | ₹104 Cr | ₹103 Cr | ₹102 Cr | ₹107 Cr | ₹107 Cr |
Operating Income | ₹56 Cr | ₹46 Cr | ₹55 Cr | ₹42 Cr | ₹51 Cr | ₹55 Cr | ₹54 Cr | ₹51 Cr |
Other Income | ₹9 Cr | ₹9 Cr | ₹8 Cr | ₹10 Cr | ₹7 Cr | ₹9 Cr | ₹14 Cr | ₹6 Cr |
Interest | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Depreciation | ₹10 Cr | ₹10 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr |
Profit Before Tax | ₹55 Cr | ₹43 Cr | ₹53 Cr | ₹42 Cr | ₹49 Cr | ₹40 Cr | ₹59 Cr | ₹48 Cr |
Profit After Tax | ₹40 Cr | ₹27 Cr | ₹39 Cr | ₹33 Cr | ₹35 Cr | ₹30 Cr | ₹43 Cr | ₹35 Cr |
EPS | ₹3.57 | ₹2.37 | ₹3.36 | ₹2.94 | ₹3.05 | ₹2.53 | ₹3.74 | ₹3.08 |
Industry Peers & Returns | 1W | 1M | 1Y |
ADVANCED ENZYME TECHNOLOGIES | 5.6% | 6.5% | -16% |
SUN PHARMACEUTICAL INDUSTRIES | -4.3% | -3% | -0.7% |
DIVIS LABORATORIES | -3.3% | -7.4% | 34.1% |
CIPLA | -4.4% | -0.5% | 0.7% |
TORRENT PHARMACEUTICALS | 1.4% | 10.1% | 17.9% |
DR REDDYS LABORATORIES | -5.2% | -5.7% | -5.9% |
MANKIND PHARMA | 0.8% | 8.4% | 26.4% |
ZYDUS LIFESCIENCES | -3.1% | -5.1% | -22.2% |
LUPIN | -4.9% | -4.6% | 0.9% |
ADVANCED ENZYME TECHNOLOGIES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 11.21 % |
Y-o-Y | 20.31 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Jun2025 | ₹186 Cr | 11.21 | |
Mar2025 | ₹167 Cr | -1.14 | |
Dec2024 | ₹169 Cr | 15.75 | |
Sep2024 | ₹146 Cr | -5.45 | |
Jun2024 | ₹155 Cr | -2.09 | |
Mar2024 | ₹158 Cr | -1.94 | |
Dec2023 | ₹161 Cr | 1.96 | |
Sep2023 | ₹158 Cr | - |
ADVANCED ENZYME TECHNOLOGIES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 23.75 % |
Y-o-Y | 10.29 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Jun2025 | ₹56 Cr | 23.75 | |
Mar2025 | ₹46 Cr | -17.47 | |
Dec2024 | ₹55 Cr | 30.27 | |
Sep2024 | ₹42 Cr | -17.10 | |
Jun2024 | ₹51 Cr | -7.59 | |
Mar2024 | ₹55 Cr | 2.99 | |
Dec2023 | ₹54 Cr | 4.77 | |
Sep2023 | ₹51 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 11.25 % |
Y-o-Y | -8.34 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Jun2025 | 30.35% | 11.25 | |
Mar2025 | 27.28% | -16.50 | |
Dec2024 | 32.67% | 12.54 | |
Sep2024 | 29.03% | -12.32 | |
Jun2024 | 33.11% | -5.62 | |
Mar2024 | 35.08% | 5.00 | |
Dec2023 | 33.41% | 2.77 | |
Sep2023 | 32.51% | - |
ADVANCED ENZYME TECHNOLOGIES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 51.30 % |
Y-o-Y | 15.62 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Jun2025 | ₹40 Cr | 51.30 | |
Mar2025 | ₹27 Cr | -31.25 | |
Dec2024 | ₹39 Cr | 16.42 | |
Sep2024 | ₹33 Cr | -4.53 | |
Jun2024 | ₹35 Cr | 17.09 | |
Mar2024 | ₹30 Cr | -29.72 | |
Dec2023 | ₹43 Cr | 20.76 | |
Sep2023 | ₹35 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 36.02 % |
Y-o-Y | -3.89 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Jun2025 | 21.75 % | 36.02 | |
Mar2025 | 15.99 % | -30.45 | |
Dec2024 | 22.99 % | 0.57 | |
Sep2024 | 22.86 % | 1.02 | |
Jun2024 | 22.63 % | 19.55 | |
Mar2024 | 18.93 % | -28.32 | |
Dec2023 | 26.41 % | 18.43 | |
Sep2023 | 22.3 % | - |
ADVANCED ENZYME TECHNOLOGIES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 50.63 % |
Y-o-Y | 17.05 % |
Quarters | EPS | % Change | |
---|---|---|---|
Jun2025 | ₹3.57 | 50.63 | |
Mar2025 | ₹2.37 | -29.46 | |
Dec2024 | ₹3.36 | 14.29 | |
Sep2024 | ₹2.94 | -3.61 | |
Jun2024 | ₹3.05 | 20.55 | |
Mar2024 | ₹2.53 | -32.35 | |
Dec2023 | ₹3.74 | 21.43 | |
Sep2023 | ₹3.08 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD